Cyanocobalamin is a synthetic form of Vitamin B12 which the body converts into Adenosylcobalamin and Methylcobalamin before it can be used
This is attributed to its ability to stimulate the production of growth factors, promote angiogenesis (the formation of new blood vessels), and elevate the levels of other proteins that support tissue regeneration
The typical patient profile for whom MIC B12 represents good value: confirmed or suspected B12 deficiency, seeking energy improvement and modest weight-loss support, not ready for or not qualifying for GLP-1 therapy, willing to self-inject weekly
as of 2026, the FDA has placed injectable GHK-Cu on its Category 2 bulk drug substances list, meaning it cannot be legally compounded for injection due to immunogenicity and impurity concerns
So for the most common long-term situation, an absorption problem, maintenance means one injection every two to three months rather than anything weekly or monthly